These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22292131)

  • 1. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies.
    McKay MM; Freeman AK; Morrison DK
    Small GTPases; 2011 Sep; 2(5):276-281. PubMed ID: 22292131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
    Brennan DF; Dar AC; Hertz NT; Chao WC; Burlingame AL; Shokat KM; Barford D
    Nature; 2011 Apr; 472(7343):366-9. PubMed ID: 21441910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CNK-HYP scaffolding complex promotes RAF activation by enhancing KSR-MEK interaction.
    Maisonneuve P; Sahmi M; Bergeron-Labrecque F; Ma XI; Queguiner J; Arseneault G; Lefrançois M; Kurinov I; Fronzes R; Sicheri F; Therrien M
    Nat Struct Mol Biol; 2024 Jul; 31(7):1028-1038. PubMed ID: 38388830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK drives BRAF activation through allosteric control of KSR proteins.
    Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
    Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions.
    Chow A; Khan ZM; Marsiglia WM; Dar AC
    Methods Enzymol; 2022; 667():365-402. PubMed ID: 35525547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras.
    Frodyma D; Neilsen B; Costanzo-Garvey D; Fisher K; Lewis R
    F1000Res; 2017; 6():1621. PubMed ID: 29026529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSR regulation of the Raf-MEK-ERK cascade.
    Ritt DA; Daar IO; Morrison DK
    Methods Enzymol; 2006; 407():224-37. PubMed ID: 16757327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KSR as a therapeutic target for Ras-dependent cancers.
    Neilsen BK; Frodyma DE; Lewis RE; Fisher KW
    Expert Opin Ther Targets; 2017 May; 21(5):499-509. PubMed ID: 28333549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A KSR/CNK complex mediated by HYP, a novel SAM domain-containing protein, regulates RAS-dependent RAF activation in Drosophila.
    Douziech M; Sahmi M; Laberge G; Therrien M
    Genes Dev; 2006 Apr; 20(7):807-19. PubMed ID: 16600912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.
    Stewart S; Sundaram M; Zhang Y; Lee J; Han M; Guan KL
    Mol Cell Biol; 1999 Aug; 19(8):5523-34. PubMed ID: 10409742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.
    Ritt DA; Zhou M; Conrads TP; Veenstra TD; Copeland TD; Morrison DK
    Curr Biol; 2007 Jan; 17(2):179-84. PubMed ID: 17174095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling.
    McKay MM; Ritt DA; Morrison DK
    Curr Biol; 2011 Apr; 21(7):563-8. PubMed ID: 21458265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors.
    Joneson T; Fulton JA; Volle DJ; Chaika OV; Bar-Sagi D; Lewis RE
    J Biol Chem; 1998 Mar; 273(13):7743-8. PubMed ID: 9516483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dimerization-dependent mechanism drives RAF catalytic activation.
    Rajakulendran T; Sahmi M; Lefrançois M; Sicheri F; Therrien M
    Nature; 2009 Sep; 461(7263):542-5. PubMed ID: 19727074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
    Roskoski R
    Pharmacol Res; 2018 Sep; 135():239-258. PubMed ID: 30118796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
    Zhou M; Horita DA; Waugh DS; Byrd RA; Morrison DK
    J Mol Biol; 2002 Jan; 315(3):435-46. PubMed ID: 11786023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
    Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.
    Zhou B; Ritt DA; Morrison DK; Der CJ; Cox AD
    J Biol Chem; 2016 Aug; 291(34):17804-15. PubMed ID: 27226552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors.
    Paniagua G; Jacob HKC; Brehey O; García-Alonso S; Lechuga CG; Pons T; Musteanu M; Guerra C; Drosten M; Barbacid M
    Mol Oncol; 2022 Sep; 16(17):3066-3081. PubMed ID: 35313064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
    Dhawan NS; Scopton AP; Dar AC
    Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.